Regulatory Publishing and Submissions

Transform compliance barriers into springboards for exponential growth ensuring seamless submissions and crafting market expansion strategies. With Freyr’s Regulatory Publishing and Submissions experts, streamline the approval processes, adhere to Regulatory guidelines, and increase the likelihood of successful product approval.

  • 300

    +

    Experts
  • 15

    +

    Average Years of Experience
  • 200

    +

    Global Customers/Clients
  • 600

    +

    Projects
  • 200000

    +

    Total Submissions
  • 1000

    +

    Original Submissions: (IND, NDA, BLA, ANDA, DMF, NDS, ANDS,  MAA, CTA) 

Regulatory Publishing and Submissions - Overview

Global Health Authorities are increasingly accepting Regulatory submissions in electronic formats. The need of the hour is to deploy robust and continually updated Regulatory Publishing and Submissions tools to manage region-wise submission documents in compliance with specific formatting requirements. Freyr ensures error-free submissions with the highest quality and has established a strong track record in delivering on-time Regulatory Publishing and Submissions services across all acceptable formats—paper, electronic submissions, eCTD, and NeeS.

Freyr assists Life Sciences organizations in streamlining the entire Regulatory Publishing and Submissions management lifecycle. This begins with Regulatory dossier development and extends through submission management, planning, tracking, publishing, and final submission to Health Authorities (HAs), including confirmation and acknowledgment for Regulatory approvals. 

With extensive regional expertise across North America (USA and Canada), Europe, LATAM, MEA, and ROW, and a team of 260+ submission experts, Freyr delivers comprehensive support for eCTD, NeeS, and paper submissions. 

In addition to expert-led services, Freyr provides access to its industry-recognized eCTD publishing and electronic submission software, Freya.Submit. This solution empowers companies to meet diverse and evolving Regulatory Publishing and Submissions requirements efficiently, enabling faster reviews and quicker approvals for products including drugs, biologics, and medical devices. 

Apart from deploying experienced experts to provide Regulatory Publishing and Submission services, Freyr offers industry-proven eCTD publishing and electronic submission software, Freya.Submit. This advanced tool enables life sciences companies to meet diverse and evolving global requirements efficiently—supporting quicker review cycles and faster product approvals for drugs, biologics, and medical devices. 

Regulatory Publishing and Submissions

  • Comprehensive Regulatory expertise offering a seamless submission support experience, backed by our dedicated team consisting of a Publishing Manager, Lead Publisher, Senior Publishing Specialist, and Document Specialist
  • Experienced global publishing network ensuring submissions with quick turnaround times
  • Responsive to last-minute submission requests and ad hoc support
  • Tailored service models, including dedicated team support for specific project requirements
  • Onshore/offshore resource flexibility to optimize cost and efficiency
  • Expert project management and technical oversight for seamless operations
  • Hassle-free system migration support
  • Clearly defined and repeatable submission processes
  • End-to-end submission tracking and management
  • Strategic submission planning for major reports and applications
  • Full compliance with Health Authority standards
  • Rigorous quality checks and review processes at every stage
  • Secure and timely dispatch services to global Health Authorities
  • Reliable archiving solutions to ensure traceability and future compliance 
  • Full-spectrum application management: NDA, BLA, IND, DMF, NDS, ANDS, MAA, CTA, and lifecycle maintenance submissions
  • Expertise in diverse submission types: Amendments, Variations, Safety Reports, Annual Reports, and Advertising/Promotional Submissions
  • Advanced eCTD 4.0 capabilities: Ensuring seamless compliance with the latest Regulatory requirements 

Success Stories

Freyr Provided Comprehensive Regulatory Support Accelerating Global Submissions and Ensuring Compliance for a Japanese Pharmaceutical and Biotechnology Company Across Multiple Markets
Publishing and Submission

Freyr Provided Comprehensive Regulatory Support Accelerating Global Submissions and Ensuring Compliance for a Japanese Pharmaceutical and Biotechnology Company Across Multiple Markets

The client, a Japanese pharmaceutical and biotechnology company, had sought to accelerate global submissions and ensure compliance. Leveraging a decade-long partnership, they had turned to Freyr for comprehensive support. Freyr provided submission planning, eCTD publishing, and submission services while expanding global resources across multiple countries. This support resulted in faster market entry and improved operational efficiency.

Freyr Streamlined and Standardized Submission Processes for a Japanese Drug Manufacturer's Successful Market Entry into the US Market
Publishing and Submission

Freyr Streamlined and Standardized Submission Processes for a Japanese Drug Manufacturer's Successful Market Entry into the US Market

The client, a Japanese drug manufacturer, had faced challenges entering the US market and needed to streamline and standardize their submission processes. They had turned to Freyr, who standardized procedures and facilitated a seamless transition from the existing vendor. Freyr's expertise resulted in faster approval cycles, strict compliance with US regulations, and enhanced operational efficiency, enabling the company to successfully enter the US market.

Freyr Provided Strategic Regulatory Partnership Achieving 100% On-Time Submissions and 50% Cost Savings with a Scalable Hybrid Staffing Model for a Japanese Midsize Global Pharma and Biotech Company
Publishing and Submission

Freyr Provided Strategic Regulatory Partnership Achieving 100% On-Time Submissions and 50% Cost Savings with a Scalable Hybrid Staffing Model for a Japanese Midsize Global Pharma and Biotech Company

A Japanese midsize global pharma and biotech company, having collaborated with Freyr for over three years, had sought Freyr's expertise for comprehensive submission publishing support in the US and Canada. Freyr had defined, implemented, and maintained best practices in publishing processes, ensuring 100% on-time submissions and achieving over 50% cost savings. This significantly boosted the company's process efficiency and compliance.

Freyr Ensured eCTD Compliance for a US-Based Multinational Company in the EAEU Region Through Expert Consultation and Transition Support from Paper to Electronic Submission Format
Publishing and Submission

Freyr Ensured eCTD Compliance for a US-Based Multinational Company in the EAEU Region Through Expert Consultation and Transition Support from Paper to Electronic Submission Format

A US-based multinational company had faced multiple Regulatory challenges with eCTD submission compliance in the EAEU region. They had turned to Freyr for comprehensive consultation support. Freyr's meticulous approach resolved their compliance concerns, resulting in rapid turnaround times, zero errors, and enhanced Regulatory efficiency.

Freyr Provided Comprehensive Regulatory Support for Managing Partial Change Applications, Renewals, and Variations for a Global Healthcare Company in China and Japan
Publishing and Submission

Freyr Provided Comprehensive Regulatory Support for Managing Partial Change Applications, Renewals, and Variations for a Global Healthcare Company in China and Japan

A global healthcare company required comprehensive Regulatory support for managing over 40+ submission operations for their gynecological products in China and Japan. They had turned to Freyr, who provided end-to-end submission services. Freyr efficiently managed the high volume of submissions, enhanced the company's operational efficiency, and ensured Regulatory compliance.

Celebrating Customers Success

 

Medicinal Products

Publishing and Submission

UK

We would like to appreciate Freyr’s quick TAT to push through an urgent submission required by the FDA. Their efficiency, diligence, excellence, sense of urgency, and priority are deeply flexibility.

Please keep up the great work as we have many milestones to achieve over the next year.

Ed Venkat

Global CMC Technical Lead

 

Medicinal Products

Publishing and Submission

UK

I am sure you have heard by now that we have received our first-ever approval from the FDA for our Brands division. This is a major milestone for us as well as for my team here in Reg Ops. I would be remiss if I didn’t point out that we would not have been able to do this without the help of your dedicated team. From the original filing, then the following year of responses, all helped get us to final approval.

Thank you Freyr team for a job well done!

Michael Bellero

Sr. Director, Head of Regulatory Operations

 

Medical Devices

Publishing and Submission​

USA

Communication and on the ground knowledge or RA requirements - this has been our experience for India. Quick to response and willing to have calls to explain requirements. Very happy with the RA work conducted in India, would use for other markets. We are satisfied. ​

Director of Regulatory Affairs​

France-based, Leading Global Supplier of Women Healthcare Products Company​